HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

NCT02379520 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Human Papillomavirus-Related Carcinoma
Human Papillomavirus Positive Oropharyngeal Carcinoma
Human Papillomavirus Positive Cervical Carcinoma
Human Papillomavirus Positive Anal Carcinoma
Human Papillomavirus Positive Vulvar Carcinoma
Human Papillomavirus Positive Penile Carcinoma

Interventions

GENETIC: HPV Specific T Cells
DRUG: Cytoxan
DRUG: Fludarabine
BIOLOGICAL: Nivolumab

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]